Celebrex-Derived Drug Targets Common Childhood Bone Tumor

Newswise — Jiayuh Lin, PhD, and colleagues at Nationwide Children’s Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex.

Read more: http://www.newswise.com/articles/celebrex-derived-drug-targets-common-childhood-bone-tumor